TickerFacts.

Company research / SBC

SBC Medical Group Holdings Inc (SBC)

Also trades as SBCWW. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001930313 · Nasdaq · Services-Offices & Clinics of Doctors of Medicine

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, SBC Medical Group Holdings Inc reported revenue of $173.61M. Revenue fell 15.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $175.17M.

Key ratios (year ended 2025-12-31)

73.3%
Gross margin
38.9%
Operating margin
29.4%
Net margin
20.5%
Return on year-end equity
-15.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-31
Revenue$175.17M$173.61M$205.42M$193.54Mn/a
Cost of Revenue$49.30M$46.32M$49.37M$56.24Mn/a
Gross Profit$125.86M$127.28M$156.05M$137.30Mn/a
Operating Income$65.41M$67.49M$70.30M$70.66Mn/a
Depreciation & Amortization$3.22M$2.68M$3.80M$12.25Mn/a
EBITDA$68.63M$70.17M$74.10M$82.91Mn/a
Net Income$49.03M$50.99M$46.61M$39.37Mn/a
EPS (Diluted)n/a$0.50$0.48$0.42n/a
Total Assets$406.66M$380.45M$266.08M$258.81M$119.94M
Total Liabilities$126.74M$117.14M$71.06M$115.00M$4.59M
Long-Term Debt$37.75M$42.83M$6.60Mn/an/a
Shareholders' Equity$263.84M$248.28M$195.11M$142.16M-$3.36M
Cash & Equivalents$184.31M$163.77M$125.04M$103.02M$485.6K
Operating Cash Flow$62.82M$24.67M$20.58M$50.67Mn/a
Capital Expenditures$1.05M$1.40M$2.56M$8.54Mn/a
Free Cash Flow$61.77M$23.27M$18.02M$42.13Mn/a
Share Repurchases$2.58M$5.00M$0n/an/a
Shares Outstanding102.58M102.58M102.75M94.19Mn/a
Weighted Average Diluted Sharesn/a103.00M96.56M94.19Mn/a
EPS (Basic)n/a$0.50$0.48$0.42n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView